A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will be the subject of an upcoming presentation at the BIO CEO & Investor Digital Conference, starting February 16. BSI is well- positioned to become the industry’s most reliable and cost-effective supplier of GMP quality QS-21 worldwide. Gaston Salinas Gaston Salinas, CEO of Botanical Solution Inc. (BSI) will address the Conference, introducing an innovative approach for the production of QS-21 based on BSI’s proprietary Advanced Botanical Materials. Mr. Salinas will also address additional issues of quality, cost and the sizeable environmental
The post QS-21, the ‘Gold Standard’ of immune system activators used in Covid-19 and other vaccines to be presented by CEO Gaston Salinas at BIO CEO & Investor Conference appeared first on Pharma Mirror Magazine.
